Comparison of clinical outcomes of ultrasonography-guided and blind local injections in facet syndrome: A 6-week randomized controlled trial

Basit Öğe Kaydı
dc.contributor.authorKarkucak, Murat
dc.contributor.authorBatmaz, Ibrahim
dc.contributor.authorKerimoglu, Servet
dc.contributor.authorAyar, Ahmet
dc.date.accessioned2024-04-24T17:20:42Z
dc.date.available2024-04-24T17:20:42Z
dc.date.issued2020
dc.departmentDicle Üniversitesien_US
dc.description.abstractBACKGROUND: Facet syndrome is defined as pain that arises from any structure of the facet joints, including the fibrous capsule, synovial membrane, hyaline cartilage, and bone. OBJECTIVES: To compare the effectiveness of US-guided and blind injections on clinical outcome in facet syndrome. MATERIALS AND METHODS: Forty-seven patients with the diagnosis of facet syndrome were included. Patients were consecutively randomized into one of the two groups. The patient's history, physical examination and routine laboratory parameters were obtained and diagnose was established based on physical findings. Two injections (mixture of 2 ml of 1% lidocaine hydrochloride and 20 mg of triamcinolone, to a single or maximum two sites depending on the clinical characteristics of the facet joint) were performed with 15 days apart, as blinded or US-guided manner. Clinical outcome assessments were carried out at 0, 2nd and 6th weeks, using Visual Analog Scale (VAS), Oswestry Disability Index (ODI) and State-Trait Anxiety Inventory (STAI). RESULTS: The patients' initial VAS and ODI were not significantly different. When the two groups were compared in the 6th week in terms of VAS scores, improvement was more pronounced in the US-guided injection group (US-guided group (n = 23) before 7.6 (2.2) cm, after 3.0 (1.7) cm, P = 0.0001 vs blind group (n = 24) before 7.2 (1.3) cm, after 5.2 (2.0) cm, P = 0.0001). The improvement in initial and 6th week ODI was statistically significant in the US-guided injection group ( P = 0.006). Except STAI I for US-group, trait anxiety scale scores were significant in both groups. CONCLUSION: The US-guided local injections offer better clinical outcome in the treatment of facet syndrome.en_US
dc.identifier.doi10.3233/BMR-181447
dc.identifier.endpage436en_US
dc.identifier.issn1053-8127
dc.identifier.issn1878-6324
dc.identifier.issue3en_US
dc.identifier.pmid31524141
dc.identifier.scopus2-s2.0-85085714548
dc.identifier.scopusqualityQ2
dc.identifier.startpage431en_US
dc.identifier.urihttps://doi.org/10.3233/BMR-181447
dc.identifier.urihttps://hdl.handle.net/11468/19203
dc.identifier.volume33en_US
dc.identifier.wosWOS:000541399000011
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherIos Pressen_US
dc.relation.ispartofJournal of Back and Musculoskeletal Rehabilitation
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFacet Jointen_US
dc.subjectInjectionen_US
dc.subjectUltrasounden_US
dc.subjectLow Back Painen_US
dc.titleComparison of clinical outcomes of ultrasonography-guided and blind local injections in facet syndrome: A 6-week randomized controlled trialen_US
dc.titleComparison of clinical outcomes of ultrasonography-guided and blind local injections in facet syndrome: A 6-week randomized controlled trial
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu